Science, a brain-computer interface company based in Alameda, California, raised $400 million in Series D funding, bringing its total funding to over $900 million. The round led this week's biggest U.S. startup funding deals.
Model ML, an AI platform serving financial and professional services, closed a $250 million Series B at a $1.5 billion valuation. General Atlantic and QED Investors led the round for the three-year-old New York and London-based company.
Galvanize Therapeutics, a Redwood City biotech developing pulsed electric field ablation technologies for oncology and chronic disease, raised $130 million in Series D funding led by HealthQuest Capital.
General Flash, which developed a new method to produce critical metals, announced $128 million across seed and Series A rounds. Ramon.Space, a Denver-based space computing infrastructure company, pulled in $124 million in Series B led by PSG.
Marrow Therapeutics launched with $173 million combined Series A and B funding. Orbimed led the $120 million Series B, while Scion Life Sciences and venBio led the $53 million Series A for the Watertown, Massachusetts-based bone marrow therapy developer.
Noeri, a Palo Alto startup developing self-improving AI for enterprises founded by Stanford computer science professors, launched with $110 million led by Menlo Ventures. Seawolf Therapeutics, a San Diego biotech with a novel DNA delivery platform, raised $100 million with Versant Ventures, MPM BioImpact and Novartis Venture Fund as leads.
BrightAI, a Silicon Valley startup building sensor and drone platforms for infrastructure monitoring, secured $97 million led by Smith Point Capital. Vincue, a Kansas City vehicle lifecycle intelligence platform, closed $93 million in growth capital led by Wavecrest Growth Partners.
Overseas, London-based Isomorphic Labs landed $5 billion in Series C for AI-driven drug discovery, led by Greenoaks and Sequoia Capital.